AstraZeneca (AZN) Short Interest Ratio & Short Volume → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free AZN Stock Alerts $65.85 -0.46 (-0.69%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AstraZeneca Short Interest DataCurrent Short Volume9,260,000 sharesPrevious Short Volume8,920,000 sharesChange Vs. Previous Month+3.81%Dollar Volume Sold Short$594.12 millionShort Interest Ratio / Days to Cover1.5Last Record DateFebruary 29, 2024Outstanding Shares3,100,410,000 sharesPercentage of Shares Shorted0.30%Today's Trading Volume3,886,482 sharesAverage Trading Volume5,133,120 sharesToday's Volume Vs. Average76% Short Selling AstraZeneca ? Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAZN Short Interest Over TimeAZN Days to Cover Over TimeAZN Percentage of Float Shorted Over Time Ad Behind the MarketsThe only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.Get the stock ticker here >>> AstraZeneca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16 2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84 1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64 1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42 12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35 12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80 Get the Latest News and Ratings for AZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59 11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13 10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23 10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33 9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72 9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27 8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82 8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51 7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70 7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38 6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57 6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62 5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08 5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99 4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22 4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86 3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41 3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58 2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18 2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69 1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37 1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08 12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80 12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74 11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97 11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95 10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81 10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97 9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84 9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14 8/31/20229,090,000 shares $567.03 million -12.5%N/A1.4 $62.38 8/15/202210,390,000 shares $694.16 million -23.8%N/A1.7 $66.81 7/31/202213,640,000 shares $903.38 million -0.2%N/A2.1 $66.23 7/15/202213,670,000 shares $920.81 million +4.2%N/A2 $67.368,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (Ad)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency AZN Short Interest - Frequently Asked Questions What is AstraZeneca's current short interest? Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been covered or closed out. As of February 29th, investors have sold 9,260,000 shares of AZN short. Learn More on AstraZeneca's current short interest. What is a good short interest ratio for AstraZeneca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 2.0. Learn More on AstraZeneca's short interest ratio. Which institutional investors are shorting AstraZeneca? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AstraZeneca: Readystate Asset Management LP, GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Citadel Advisors LLC, Optiver Holding B.V., Goldman Sachs Group Inc., IMC Chicago LLC, Worth Venture Partners LLC, UBS Group AG, Concourse Financial Group Securities Inc., and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AstraZeneca's short interest increasing or decreasing? AstraZeneca saw a increase in short interest in the month of February. As of February 29th, there was short interest totaling 9,260,000 shares, an increase of 3.8% from the previous total of 8,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AstraZeneca's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to AstraZeneca: Abbott Laboratories (0.87%), Novartis AG (0.22%), Pfizer Inc. (1.17%), Sanofi (0.17%), Bristol-Myers Squibb (1.62%), Merck & Co., Inc. (0.66%), Vertex Pharmaceuticals Incorporated (1.57%), Regeneron Pharmaceuticals, Inc. (1.24%), AbbVie Inc. (0.81%), GSK plc (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short AstraZeneca stock? Short selling AZN is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZN shares are trading down $0.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AstraZeneca? A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further. How often is AstraZeneca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: ABT Short Squeeze NVS Short Squeeze PFE Short Squeeze SNY Short Squeeze BMY Short Squeeze MRK Short Squeeze VRTX Short Squeeze REGN Short Squeeze ABBV Short Squeeze GSK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AZN) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Companytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency